![]() |
|
|
RESÚMENES DICIEMBRE 2009 |
Mood - Anxiety
Disorders & Antidepressants – Mood Stabilizers
(Haga un click
en la información del journal para acceder al resúmen)
5
– doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3
– revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto
gratuito en algunos países de la región iberoamericana
3 - Late-life depression in
Peru, Mexico and Venezuela: the 10/66 population-based study
Mariella Guerra, Cleusa P. Ferri, Ana Luisa Sosa,
Aquiles Salas, Ciro Gaona, Victor Gonzales, Gabriela Rojas de la Torre, Martin
Prince
The British Journal of
Psychiatry (2009) 195: 510-515
3 - Lithium and thyroid
3! - Differential inhibitory
effects of drugs acting at the noradrenaline and 5-hydroxytryptamine
transporters in rat and human neocortical synaptosomes
M Mantovani, DJ Dooley, A Weyerbrock, R Jackisch and TJ Feuerstein
British Journal of Pharmacology. Volume 158 Issue
7, Pages 1848 - 1856
3 - An
update of evidence-based treatment of bipolar depression: where do we stand?
Fountoulakis, Konstantinos N
Current Opinion in Psychiatry: January 2010 -
Volume 23 - Issue 1 - p 19-24
3! - Effects of Duloxetine on the Pharmacodynamics and Pharmacokinetics of
Warfarin at Steady State in Healthy Subjects
Jill
Chappell, Jingsong He, Mary Pat Knadler, Malcolm Mitchell, Douglas Lee, and
Evelyn Lobo
J Clin Pharmacol
2009 49: 1456 -1466
4! - Relapse Prevention and Residual Symptoms: A Closer Analysis of
Placebo-Controlled Continuation Studies With Escitalopram in Major Depressive
Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and
Obsessive-Compulsive Disorder
Per
Bech, Sara L. Lönn, and Kerstin F. Overø
J Clin Psychiatry. December 1, 2009
3 - Cigarette Smoking and Panic: A Critical Review of the Literature
Fiammetta
Cosci, Inge J. E. Knuts, Kenneth Abrams, Eric J. L. Griez, and Koen R. J.
Schruers
J Clin Psychiatry. December 1,
2009
4 - Quetiapine XR efficacy and tolerability as
monotherapy and as adjunctive treatment to conventional antidepressants in the
acute and maintenance treatment of major depressive disorder: a review of
registration trials
Roger S McIntyre
Expert Opinion on Pharmacotherapy. December 2009, Vol.
10, No. 18, Pages 3061-3075
3 -
Relative Ineffectiveness of Ultrabrief Right Unilateral Versus Bilateral
Electroconvulsive Therapy in Depression
McCormick, Laurie M; Brumm,
Michael C; Benede, Ajith K; Lewis, Jerry L
The Journal of ECT: December 2009 - Volume 25 -
Issue 4 - pp 238-242
GRATIS 3! - Suicidal ideation during
treatment of depression with escitalopram and nortriptyline in Genome-Based
Therapeutic Drugs for Depression (GENDEP): a clinical trial
Nader Perroud, Rudolf Uher,
Andrej Marusic, Marcella Rietschel, Ole Mors, Neven Henigsberg, Joanna Hauser,
Wolfgang Maier, Daniel Souery, Anna Placentino, Aleksandra Szczepankiewicz, Lisbeth
Jorgensen, Jana Strohmaier, Astrid Zobel, Caterina Giovannini, Amanda Elkin,
Cerisse Gunasinghe, Joanna Gray, Desmond Campbell, Bhanu Gupta, Anne E Farmer,
Peter McGuffin and Katherine J Aitchison
3! - Genetic Predictors of Increase in Suicidal Ideation
During Antidepressant Treatment in the GENDEP Project
&
Neuropsychopharmacology 34, 2517–2528 (1 November 2009)
3! - Residual symptoms after remission of major depressive disorder with
citalopram and risk of relapse: a STAR*D report
A. A. Nierenberg, M. M.
Husain, M. H. Trivedi, M. Fava, D. Warden, S. R. Wisniewski, S. Miyahara and A.
J. Rush
Psychological
Medicine (2010), 40:41-50
3 - The 2-year prognosis of panic episodes in the general population
N. M. Batelaan, R. de
Graaf, B. W. J. H. Penninx, A. J. L. M. van Balkom, W. A. M. Vollebergh and A.
T. F. Beekman
Psychological
Medicine (2010), 40:147-157
3 -
Atypical Depression: A Comprehensive Review
Pae, Chi-Un; Tharwani, Haresh;
Marks, David M; Masand, Prakash S; Patkar, Ashwin A
CNS Drugs: 1 December 2009 - Volume 23 - Issue
12 - pp 1023-1037
3 -
Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder:
A Preliminary, Single-Blind, Prospective Study
Pallanti, Stefano; Bernardi,
Silvia; Antonini, Sarah; Singh, Nikhilesh; Hollander, Eric
CNS Drugs: 1 December 2009 - Volume 23 - Issue
12 - pp 1047-1055
3! - Renal failure occurs in
chronic lithium treatment but is uncommon
Bendz
H, Schön S, Attman PO, Aurell M
Kidney Int. 2009 Nov 25. [Epub ahead of print]
3! - Brain Monoamine Oxidase A Binding in Major Depressive Disorder. Relationship to Selective
Serotonin Reuptake Inhibitor Treatment, Recovery, and Recurrence
Jeffrey H. Meyer, Alan A.
Wilson, Sandra Sagrati, Laura Miler, Pablo Rusjan, Peter M. Bloomfield, Michael
Clark, Julia Sacher, Aristotle N. Voineskos, Sylvain Houle
Arch Gen Psychiatry. 2009;66(12):1304-1312
5 - Personality Change During
Depression Treatment. A
Placebo-Controlled Trial
Tony Z. Tang, Robert J.
DeRubeis, Steven D. Hollon, Jay Amsterdam, Richard Shelton, Benjamin Schalet
Arch Gen Psychiatry. 2009;66(12):1322-1330
3! - Heterogeneity of DSM-IV
Major Depressive Disorder as a Consequence of Subthreshold Bipolarity
Petra Zimmermann, Tanja
Brückl, Agnes Nocon, Hildegard Pfister, Roselind Lieb, Hans-Ulrich Wittchen,
Florian Holsboer, Jules Angst
Arch Gen Psychiatry. 2009;66(12):1341-1352
3! - Relationship Between Antiepileptic Drugs and Suicide Attempts in
Patients With Bipolar Disorder
Robert D. Gibbons, Kwan Hur,
C. Hendricks Brown, J. John Mann
Arch Gen Psychiatry. 2009;66(12):1354-1360
3! -
Stressful Life Events and Depressive Symptoms: Influences of Gender, Event
Severity, and Depression History
You, Sungeun; Conner, Kenneth R
The Journal of Nervous and Mental Disease:
November 2009 - Volume 197 - Issue 11 - pp 829-833
3! - Sex
Differences in the Prevalence of Post-Stroke Depression: A Systematic Review
Brittany Poynter, Mira Shuman,
Natalia Diaz-Granados, Moira Kapral, Sherry L. Grace, and Donna E. Stewart
Psychosomatics 50:563-569, November-December
2009
2 -
Treatment of Resistant Obsessive-Compulsive Disorder With Ventral
Capsular/Ventral Striatal Gamma Capsulotomy: A Pilot Prospective Study
Antonio Carlos Lopes, Benjamin D. Greenberg, Georg
Norén, Miguel Montes Canteras, Geraldo F. Busatto, Maria Eugênia de Mathis,
Anita Taub, Carina Chaubet D’Alcante, Marcelo Queiroz Hoexter, Fernando
Sauerbronn Gouvea, Janaína Philippi Cecconi, André F. Gentil, Ygor Arzeno
Ferrão, Daniel Fuentes, Cláudio Campi de Castro, Cláudia C. Leite, João Victor
Salvajoli, Fábio L. S. Duran, Steven Rasmussen, and Eurípedes Constantino
Miguel
J Neuropsychiatry Clin Neurosci 21:381-392,
Fall
3 - Invasive Circuitry-Based Neurotherapeutics:
Stereotactic Ablation and Deep Brain Stimulation for OCD
Benjamin D Greenberg,
Scott L Rauch and Suzanne N Haber
Neuropsychopharmacology (2010) 35, 317–336
5 - Milnacipran and
venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment
of adults with moderate-to-severe major depressive disorder: A 24-week
randomised, double blind exploratory study
J.-P.
Olié, D. Gourion, A. Montagne, M. Rostin and M.-F. Poirier
L'Encéphale. Volume 35, Issue 6, December 2009,
Pages 595-604
3! - Chronic renal
complications induced by lithium
V. Le
Roy, Y. Delmas and H. Verdoux
L'Encéphale. Volume 35, Issue 6, December 2009,
Pages 605-610
4< - Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory,
post-hoc analysis of a randomized, double blind study
Papakostas, George I; Clain,
Alisabet; Ameral, Victoria E; Baer, Lee; Brintz, Carrie; Smith, Ward T;
Londborg, Peter D; Glaudin, Vincent; Painter, John R; Fava, Maurizio
International Clinical Psychopharmacology:
January 2010 - Volume 25 - Issue 1 - pp 17-21
3 - Cardiac Effects of Vagus Nerve Stimulation in
Patients with Major Depression
W. Sperling, U. Reulbach, S. Bleich,
F. Padberg, J. Kornhuber, M. Mueck-Weymann
Pharmacopsychiatry. December 9, 2009
3! - Darwinian dynamics of depression
John Price
Australian and New Zealand Journal of Psychiatry. November
2009, Vol. 43, No. 11, Pages 1029-1037
2 - Syndrome
of Inappropriate Antidiuretic Hormone Secretion (SIADH) or Hyponatraemia
Associated with Valproic Acid: Four Case Reports from the Netherlands and a
Case/Non-Case Analysis of Vigibase
Beers, Erna; van Puijenbroek,
Eugène P; Bartelink, Imke H; van der Linden, Carolien M.J; Jansen, Paul A.F
Drug Safety: 1 January 2010 - Volume 33 - Issue
1 - pp 47-55
3 - A link between stress and
mood disorders
Francesca
Calabrese, Raffaella Molteni, Giorgio Racagni and Marco A. Riva
Psychoneuroendocrinology.
Volume 34, Supplement
1, December 2009, Pages S208-S216
3! - Regulation of adult
neurogenesis by stress, sleep disruption, exercise and inflammation:
Implications for depression and antidepressant action
P.J.
Lucassen, P. Meerlo, A.S. Naylor, A.M. van Dam, A.G. Dayer, E. Fuchs, C.A.
Oomen and B. Czéh
European
Neuropsychopharmacology. Volume
20, Issue 1, January 2010, Pages 1-17
3 -
Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine
in unipolar depression: An open-label study
Cornelius
Schule;
Thomas C. Baghai; Daniela Eser; Caroline Nothdurfter; Rainer
Rupprecht
World Journal of Biological Psychiatry, Volume
10, Issue 5 December 2009, pages 390 - 399
3 - Are
there differences between serotonergic, noradrenergic and dual acting
antidepressants in the treatment of depressed women?
Salih
Saygin Eker; Selcuk Kirli; Cengiz Akkaya; Sengul Cangur; Asli
Sarandol
World Journal of Biological Psychiatry, Volume
10, Issue 5 December 2009, pages 400 - 408
3! -
Treatment of unipolar psychotic depression: The use of evidence in practice
guidelines
Jaap
Wijkstra; Chris D. Schubart; Willem A. Nolen
World Journal of Biological Psychiatry, Volume
10, Issue 5 December 2009, pages 409 - 415
3 - Lower
rates of comorbidities in euthymic bipolar patients
Fabiana Nery-Fernandes;
Lucas C. Quarantini; Amanda Galvao-De-Almeida; Marlos
V. Rocha; Flavio Kapczinski; Angela
Miranda-Scippa
World Journal of Biological Psychiatry, Volume
10, Issue 5 December 2009, pages 474 - 479
3! -
Trazodone generates m-CPP: In 2008 risks from m-CPP might outweigh benefits of
trazodone
Richard
E. Kast
World Journal of Biological Psychiatry, Volume
10, Issue 5 December 2009, pages 682 - 685
3! -
Tryptophan as an evolutionarily conserved signal to brain serotonin: Molecular
evidence and psychiatric implications
Sascha
Russo; Ido P. Kema; Fokko Bosker; Jan Haavik; Jakob Korf
World Journal of Biological Psychiatry, Volume
10, Issue 4 November 2009, pages 258 - 268
3 - Sleep
disturbances: Core symptoms of major depressive disorder rather than associated
or comorbid disorders
Julien
Mendlewicz
World Journal of Biological Psychiatry, Volume
10, Issue 4 November 2009, pages 269 - 275
3 -
Neurotrophic factors in serum following ECT: A pilot study
Ole Gronli; Geir Oyvind Stensland;
Rolf Wynn; Reidun Olstad
World Journal of Biological Psychiatry, Volume
10, Issue 4 November 2009, pages 295 - 301
3 -
Pro-inflammatory biomakers in depression: Treatment with venlafaxine
John E.
Piletz; Angelos Halaris; Omer Iqbal; Debra
Hoppensteadt; Jawed Fareed; He Zhu; James Sinacore; C.
Lindsay DeVane
World Journal of Biological Psychiatry, Volume
10, Issue 4 November 2009, pages 313 - 323
3! - Nucleus Accumbens Deep
Brain Stimulation Decreases Ratings of Depression and Anxiety in
Treatment-Resistant Depression
Bettina
H. Bewernick, René Hurlemann, Andreas Matusch, Sarah Kayser, Christiane
Grubert, Barbara Hadrysiewicz, Nikolai Axmacher, Matthias Lemke, Deirdre
Cooper-Mahkorn, Michael X. Cohen, Holger Brockmann, Doris Lenartz, Volker Sturm
and Thomas E. Schlaepfer
Biological
Psychiatry. Volume 67,
Issue 2, 15 January 2010, Pages 110-116
3 - Antidepressant-Like
Effects of Medial Prefrontal Cortex Deep Brain Stimulation in Rats
Clement
Hamani, Mustansir Diwan, Carlos E. Macedo, Marcus L. Brandão,
Jason Shumake, Francisco Gonzalez-Lima, Roger Raymond, Andres M. Lozano, Paul
J. Fletcher and José N. Nobrega
Biological
Psychiatry. Volume 67,
Issue 2, 15 January 2010, Pages 117-124
3 - Site-Specific
Antidepressant Effects of Repeated Subconvulsive Electrical Stimulation:
Potential Role of Brain-Derived Neurotrophic Factor
Roman
Gersner, Erika Toth, Moshe Isserles and Abraham Zangen
Biological
Psychiatry. Volume 67,
Issue 2, 15 January 2010, Pages 125-132
3 - A Genomewide Association
Study of Citalopram Response in Major Depressive Disorder
Holly
A. Garriock, Jeffrey B. Kraft, Stanley I. Shyn, Eric J. Peters, Jennifer S.
Yokoyama, Gregory D. Jenkins, Megan S. Reinalda, Susan L. Slager, Patrick J.
McGrath and Steven P. Hamilton
Biological
Psychiatry. Volume 67,
Issue 2, 15 January 2010, Pages 133-138
3 - Safety and Efficacy of
Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije
aan het Rot, Katherine A. Collins, James W. Murrough, Andrew M. Perez, David L.
Reich, Dennis S. Charney and Sanjay J. Mathew
Biological
Psychiatry. Volume 67,
Issue 2, 15 January 2010, Pages 139-145
3 - Synaptic Adaptations of
CA1 Pyramidal Neurons Induced by a Highly Effective Combinational
Antidepressant Therapy
Cristina
Marchetti, Elisiana Tafi, Silvia Middei, Maria A. Rubinacci, Leonardo Restivo,
Martine Ammassari-Teule and Hélène Marie
Biological
Psychiatry. Volume 67,
Issue 2, 15 January 2010, Pages 146-154
3 - The origins of
electroconvulsive therapy: Prof. Bini's first report on ECT
Gianni
L. Faedda, Ina Becker, Argelinda Baroni, Leonardo Tondo, Ellen Aspland and
Athanasios Koukopoulos
Journal of Affective
Disorders. Volume 120,
Issues 1-3, January 2010, Pages 12-15
3 - Rethinking depression and
the actions of antidepressants: Uncovering the links between the neural and
behavioral elements
Martin
M. Katz, Charles L. Bowden and Alan Frazer
Journal of Affective
Disorders. Volume 120,
Issues 1-3, January 2010, Pages 16-23
3! - Clinical features of
patients with treatment-emergent suicidal behavior following initiation of
paroxetine therapy
John
E. Kraus, Joseph P. Horrigan, David J. Carpenter, Regan Fong, Pamela S. Barrett
and John T. Davies
Journal of Affective
Disorders. Volume 120,
Issues 1-3, January 2010, Pages 40-47
3 - The effectiveness of
continuation-maintenance ECT in reducing depressed older patients' hospital
re-admissions
Daniel
W. O'Connor, Betina Gardner, Ian Presnell, Dhiren Singh, Maria Tsanglis and
Erica White
Journal of Affective
Disorders. Volume 120,
Issues 1-3, January 2010, Pages 62-66
4! - Early improvement is a
predictor of treatment outcome in patients with mild major, minor or
subsyndromal depression
André
Tadić, Isabella Helmreich, Roland Mergl, Martin Hautzinger, Ralf Kohnen, Verena
Henkel and Ulrich Hegerl
Journal of Affective
Disorders. Volume 120,
Issues 1-3, January 2010, Pages 86-93
3 - Economic evaluation of
duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in
treating major depressive disorder in Scotland
Ágnes
Benedict, Jorge Arellano, Erwin De Cock and Jessamy Baird
Journal of Affective
Disorders. Volume 120,
Issues 1-3, January 2010, Pages 94-104
3 - Subgenual cingulate and
visual cortex responses to sad faces predict clinical outcome during
antidepressant treatment for depression
Paul
A. Keedwell, Dominique Drapier, Simon Surguladze, Vincent Giampietro, Mick
Brammer and Mary Phillips
Journal of Affective
Disorders. Volume 120,
Issues 1-3, January 2010, Pages 120-125
4 - Effects of aripiprazole
adjunctive to standard antidepressant treatment on the core symptoms of
depression: A post-hoc, pooled
analysis of two large, placebo-controlled studies
J.
Craig Nelson, Raymond Mankoski, Ross A. Baker, Berit X. Carlson, James M.
Eudicone, Andrei Pikalov, Quynh-Van Tran and Robert M. Berman
Journal of Affective
Disorders. Volume 120,
Issues 1-3, January 2010, Pages 133-140
3! - Pregnancy outcomes among
women with panic disorder — Do panic attacks during pregnancy matter?
Yi-Hua
Chen, Herng-Ching Lin and
Hsin-Chien Lee
Journal of Affective
Disorders. Volume 120,
Issues 1-3, January 2010, Pages 258-262
3! - Antidepressant Use and Risk of Incident Cardiovascular Morbidity and
Mortality Among Postmenopausal Women in the Women's Health Initiative Study
Jordan W. Smoller, Matthew
Allison, Barbara B. Cochrane, J. David Curb, Roy H. Perlis, Jennifer G.
Robinson, Milagros C. Rosal, Nanette K. Wenger, Sylvia Wassertheil-Smoller
Arch Intern Med. 2009;169(22):2128-2139
4 - Serotonergic and Noradrenergic Modulation of Emotion
Processing by Single Dose Antidepressants
Annette Beatrix Brühl,
Tina Kaffenberger and Uwe Herwig
Neuropsychopharmacology (2010) 35, 521–533
5 - Levetiracetam in
Generalized Social Anxiety Disorder: A Double-Blind, Randomized Controlled
Trial
Murray B. Stein, Lakshmi N.
Ravindran, Naomi M. Simon, Michael R. Liebowitz, Arifulla Khan, Olga
Brawman-Mintzer, R. Bruce Lydiard, and Mark H. Pollack
J Clin Psychiatry.
Online ahead of print: December 15, 2009
3 - Impact
of Substance Use Disorders on Recovery From Episodes of Depression in Bipolar
Disorder Patients: Prospective Data From the Systematic Treatment Enhancement
Program for Bipolar Disorder (STEP-BD)
Michael J. Ostacher, Roy H.
Perlis, Andrew A. Nierenberg, Joseph Calabrese, Jonathan P. Stange, Ihsan
Salloum, Roger D. Weiss, Gary S. Sachs, and for STEP-BD Investigators
Am J Psychiatry Published December 15, 2009
5 -
Combination of Antidepressant Medications From Treatment Initiation for Major
Depressive Disorder: A Double-Blind Randomized Study
Pierre Blier, Herbert E. Ward,
Philippe Tremblay, Louise Laberge, Chantal Hébert, and Richard Bergeron
Am J Psychiatry Published December 15, 2009
3 - Effects of Duloxetine in Treatment-Refractory Men
with Posttraumatic Stress Disorder
E. Walderhaug, S. Kasserman,
D. Aikins, D. Vojvoda, C. Nishimura, A. Neumeister
Pharmacopsychiatry. Janueary 2010
3! - What Is Hypomania?
Tetrachoric Factor Analysis and Kernel Estimation of DSM-IV Hypomanic Symptoms
Franco Benazzi
J Clin Psychiatry
2009;70(11):1514–1521
5< -
Double-Blind Study of Dextroamphetamine Versus Caffeine Augmentation for
Treatment-Resistant Obsessive-Compulsive Disorder
Lorrin M. Koran, Elias
Aboujaoude, and Nona N. Gamel
J Clin Psychiatry
2009;70(11):1530–1535
5 - Olanzapine-Divalproex
Combination Versus Divalproex Monotherapy in the Treatment of Bipolar Mixed
Episodes: A Double-Blind, Placebo-Controlled Study
John P. Houston, Mauricio
Tohen, Elisabeth K. Degenhardt, Hassan H. Jamal, Lin L. L. Liu, and Terence A.
Ketter
J Clin Psychiatry
2009;70(11):1540–1547
5 - Next-Step Strategies for
Panic Disorder Refractory to Initial Pharmacotherapy: A 3-Phase Randomized
Clinical Trial
Naomi M. Simon, Michael W.
Otto, John J. Worthington, Elizabeth A. Hoge, Elizabeth H. Thompson, Richard T.
LeBeau, Samantha J. Moshier, Alyson K. Zalta, and Mark H. Pollack
J Clin Psychiatry
2009;70(11):1563–1570
3! - Effects of Lithium on
Cognitive Performance: A Meta-Analysis
Aliza P. Wingo, Thomas S.
Wingo, Philip D. Harvey, and Ross J. Baldessarini
J Clin Psychiatry
2009;70(11):1588–1597
3 -
Sex-Specific Effects of Chronic Fluoxetine Treatment on Neuroplasticity and
Pharmacokinetics in Mice
Georgia
E. Hodes, Tiffany E. Hill-Smith, Raymond F. Suckow, Thomas B. Cooper
and Irwin Lucki
JPET
January 2010 vol. 332 no. 1 266-273
3! - Effect of Age, Weight,
and CYP2C19 Genotype on Escitalopram Exposure
Yuyan Jin, Bruce G. Pollock,
Ellen Frank, Giovanni B. Cassano, Paola Rucci, Daniel J. Müller, James L.
Kennedy, Rocco Nicola Forgione, Margaret Kirshner, Gail Kepple, Andrea
Fagiolini, David J. Kupfer, and Robert R. Bies
J Clin Pharmacol 2010;50(1):62
5 -
Genetic polymorphisms in the treatment of depression: Speculations from an
augmentation study using atomoxetine
Frederick
Reimherr, Jay Amsterdam, David Dunner, Lenard Adler, Shuyu Zhang, David
Williams, Barrie Marchant, David Michelson, Andrew Nierenberg, Alan Schatzberg and
Peter Feldman
Psychiatry Research. Volume 175, Issues 1-2, 30 January
2010, Pages 67-73
3 -
Changes in hypothalamic–pituitary–thyroid axis following successful treatment
with low-frequency right prefrontal transcranial magnetic stimulation in
treatment-resistant depression
Shinsuke
Kito, Takashi Hasegawa, Kenichi Fujita and Yoshihiko Koga
Psychiatry Research. Volume 175, Issues 1-2, 30 January
2010, Pages 74-77
3 -
Genetic associations of prolactin increase in olanzapine/fluoxetine
combination-treated patients
John
P. Houston, Bonnie Fijal, Alexandra N. Heinloth and David H. Adams
Psychiatry Research. Volume 175, Issues 1-2, 30 January
2010, Pages 171-172
3 -
Phenotypic effects of a bipolar liability gene among individuals with major
depressive disorder
Francesco
Casamassima, Jie Huang, Maurizio Fava, Gary S. Sachs, Jordan W. Smoller,
Giovanni B. Cassano, Lorenzo Lattanzi, Jes Fagerness, Jonathan P.
Stange, Roy H. Perlis
3 - Epilepsy and bipolar disorders
Marco
Mula, Antonella Ester Marotta and Francesco Monaco
Expert Review of Neurotherapeutics. January 2010, Vol. 10, No. 1, Pages
13-23
3 - Therapy-resistant depression
Tom
Bschor
Expert Review of Neurotherapeutics. January 2010, Vol. 10, No. 1, Pages
77-86
GRATIS 2 - Fluvoxamine monotherapy for psychotic depression: the
potential role of sigma-1 receptors
Tsutomu Furuse and Kenji Hashimoto
Annals of General Psychiatry 2009, 8:26
4 - Genetic Association Study
of Treatment Response With Olanzapine/Fluoxetine Combination or Lamotrigine in
Bipolar I Depression
Roy H. Perlis, David H.
Adams, Bonnie Fijal, Virginia K. Sutton, Mark Farmen, Alan Breier and John P.
Houston
J Clin Psychiatry. Online
ahead of print: December 15, 2009
4 - Safety and Tolerability of
Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc
Analysis (studies CN138-139 and CN138-163)
J. Craig Nelson, Michael E.
Thase, Madhukar H. Trivedi, Maurizio Fava, Jian Han, Quynh Van Tran, Andrei
Pikalov, Ying Qi, Berit X. Carlson, Ronald N. Marcus, and Robert M. Berman
Prim Care Companion
J Clin Psychiatry 2009;11(6):344-352
3! - The epidemiology of obsessive-compulsive
disorder in the National Comorbidity Survey Replication
A
M Ruscio, D J Stein, W T Chiu and R C Kessler
Molecular Psychiatry (2010) 15, 53–63
3 - Deep brain stimulation of the ventral
internal capsule/ventral
striatum for obsessive-compulsive disorder: worldwide experience
B
D Greenberg, L A Gabriels, D A Malone Jr, A R Rezai, G
M Friehs, M S Okun, N A Shapira, K D Foote, P
R Cosyns, C S Kubu, P F Malloy, S P Salloway, J
E Giftakis, M T Rise, A G Machado, K B Baker, P
H Stypulkowski, W K Goodman, S A Rasmussen and B J Nuttin
Molecular Psychiatry (2010) 15, 64–79
4 - Rapid antipsychotic
response with ziprasidone predicts subsequent acute manic/mixed episode
remission
Terence
A. Ketter, Ofer Agid, Shitij Kapur, Antony Loebel, Cynthia O. Siu and Steven J.
Romano
Journal of
Psychiatric Research. Volume 44,
Issue 1, January 2010, Pages 8-14
3 - Adjuvant use of
nutritional and herbal medicines with antidepressants, mood stabilizers and
benzodiazepines
Jerome
Sarris, David J. Kavanagh and Gerard Byrne
Journal of
Psychiatric Research. Volume 44,
Issue 1, January 2010, Pages 32-41
3! - Safety
Reporting and Adverse-Event Profile of Mirtazapine Described in Randomized
Controlled Trials in Comparison with Other Classes of Antidepressants in the
Acute-Phase Treatment of Adults with Depression: Systematic Review and
Meta-Analysis
Watanabe, Norio; Omori, Ichiro
M; Nakagawa, Atsuo; Cipriani, Andrea; Barbui, Corrado; McGuire, Hugh; Churchill,
Rachel; Furukawa, Toshi A; on behalf of the MANGA (Meta-Analysis of New
Generation Antidepressants) Study Group
CNS Drugs: 1 January
2010 - Volume 24 - Issue 1 - pp 35-53
3! - Long-term developmental
outcome of children of women with epilepsy, unexposed or exposed prenatally to
antiepileptic drugs: a meta-analysis of cohort studies
Banach
R, Boskovic R, Einarson T, Koren G
3 - The course of panic
attacks in individuals with panic disorder and subthreshold panic disorder: A
population-based study
Neeltje M. Batelaan, Ron de Graaf, Jan Spijker, Jan
H. Smit, Anton J.L.M. van Balkom, Wilma A.M. Vollebergh and Aartjan T.F. Beekman
Journal
of Affective Disorders. Volume 121,
Issues 1-2, February 2010, Pages 30-38
3! - Maternal bipolar disorder
increased low birthweight and preterm births: A nationwide population-based
study
Hsin-Chien
Lee and Herng-Ching Lin
Journal
of Affective Disorders. Volume 121,
Issues 1-2, February 2010, Pages 100-105
5 - Effectiveness of the
extended release formulation of quetiapine as monotherapy for the treatment of
acute bipolar depression
Trisha
Suppes, Catherine Datto, Margaret Minkwitz, Arvid Nordenhem, Chris Walker and
Denis Darko
Journal
of Affective Disorders. Volume 121,
Issues 1-2, February 2010, Pages 106-115
3! - Maintenance treatment
received by patients with bipolar I and II disorders — A naturalistic
prospective study
Petri
Arvilommi, Kirsi Suominen, Outi Mantere, Sami Leppämäki, Hanna M. Valtonen and
Erkki Isometsä
Journal
of Affective Disorders. Volume 121,
Issues 1-2, February 2010, Pages 116-126
3! - Early stages in the
development of bipolar disorder
Anne
Duffy, Martin Alda, Tomas Hajek, Simon B. Sherry and Paul Grof
Journal
of Affective Disorders. Volume 121,
Issues 1-2, February 2010, Pages 127-135
3! - Onset-age of bipolar
disorders at six international sites
R.J.
Baldessarini, L. Bolzani, N. Cruz, P.B. Jones, M. Lai, B. Lepri, J. Perez, P.
Salvatore, M. Tohen, L. Tondo and E. Vieta
Journal
of Affective Disorders. Volume 121,
Issues 1-2, February 2010, Pages 143-146
3 - Dimensional predictors of
response to SRI pharmacotherapy in obsessive–compulsive disorder
Angeli Landeros-Weisenberger, Michael H. Bloch, Ben
Kelmendi, Ryan Wegner, Jake Nudel, Philip Dombrowski, Christopher Pittenger,
John H. Krystal, Wayne K. Goodman, James F. Leckman and Vladimir Coric
Journal
of Affective Disorders. Volume 121,
Issues 1-2, February 2010, Pages 175-179
3! - Effects of acute tryptophan depletion in serotonin reuptake
inhibitor-remitted patients with generalized anxiety disorder
Sean D. Hood,
Dana A. Hince, Simon J. C. Davies,
Spilios Argyropoulos, Hayley Robinson, John Potokar and
David J. Nutt
Psychopharmacology. Volume
208, Number 2 / February, 2010: 223-232
GRATIS (previo registro) 3!
- Efectos de la edad, del sexo y del
índice de masa corporal en las concentraciones plasmáticas de citalopram y
demetilcitalopram en pacientes adultos y ancianos
C.A. de Mendonça-Lima, P.
Baumann, M. Brawand-Amey, C. Brogli, S. Jacquet, N. Cochard, K. Powell-Golay,
C.B. Eap
PSICOGERIATRÍA
2009; 1 (4): 201-207
3 - Enhancing medication
adherence in patients with bipolar disorder
Lesley Berk, Karen T. Hallam, Francesc Colom, Eduard
Vieta, Melissa Hasty, Craig Macneil, Michael Berk
Human Psychopharmacology: Clinical
and Experimental. Volume 25 Issue
1, Pages 1 - 16
3 - Olanzapine monotherapy for
acute depression in patients with bipolar I or II disorder: results of an
8-week open label trial
William V. Bobo, Richard A. Epstein, Richard C.
Shelton
Human Psychopharmacology: Clinical
and Experimental. Volume 25 Issue
1, Pages 30 - 36
4 - Anxiety does not predict
response to duloxetine in major depression: results of a pooled analysis of
individual patient data from 11 placebo-controlled trials
J. Craig Nelson
Depression and Anxiety. Volume 27 Issue
1, Pages 12 - 18
3 - Major depression: the
importance of clinical characteristics and treatment response to prognosis
Wayne Katon, Jürgen Unützer, Joan Russo
Depression and Anxiety. Volume 27 Issue
1, Pages 19 - 26
3! - Adverse effects of
antidepressant use in pregnancy: an evaluation of fetal growth and preterm birth
A.
Einarson, J. Choi, T.R. Einarson, G. Koren
Depression and Anxiety. Volume 27 Issue
1, Pages 35 - 38
3! - Ethnic differences in
antidepressant response: a prospective multi-site clinical trial
Ira M. Lesser, Hector F. Myers, Keh-Ming Lin, Consuelo
Bingham Mira, Nataria T. Joseph, Natasha T. Olmos, Jonathan Schettino, Russell
E. Poland
Depression and Anxiety. Volume 27 Issue
1, Pages 56 - 62
3! - Influence of Anesthetic Drugs and Concurrent Psychiatric Medication on
Seizure Adequacy During Electroconvulsive Therapy
Bogata
D. Bundy, Walter Hewer, Franz-Josef Andres, Peter Gass, and Alexander Sartorius
J Clin Psychiatry. Online
ahead of print: December 29, 2009
GRATIS 3 - Low-dose Transdermal Testosterone Augmentation
Therapy Improves Depression Severity in Women
Karen K. Miller, Roy H. Perlis, George I.
Papakostas, David Mischoulon, Dan V. Iosifescu, Danielle J. Brick, and Maurizio
Fava
CNS
Spectr. 2009;14(12):688-694
3 - STAR* D study: searching strategies regarding lack of
response to an SSRI
Zaratiegui
R
Vertex. 2009
Mar-Apr;20(84):119-28
| Regresar a RESÚMENES DICIEMBRE 2009 |
© 1999-2009 Jorge M
Tamayo, MD, BMSS
Creada en Enero 1999
Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.